Additionally, CHEPLAPHARM acquires Glenwood LLC based in New York, USA.
CHEPLAPHARM continues its rapid growth in 2013. The increase in sales...Read more
CHEPLAPHARM acquires the rights for VESANOID® and ROHYPNOL® - largest investment since company´s existence.
Products are attained from F. Hoffmann-La Roche and will be exported to more than 90 countries.
Mesekenhagen-based CHEPLAPHARM Arzneimittel GmbH from...Read more
Pharmaceutical product was taken over from AstraZeneca and is distributed in Europe
CHEPLAPHARM, headquartered in Mesekenhagen (Mecklenburg-Western...Read more